Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives.
Lee JM, McNamee CJ, Toloza E, Negrao MV, Lin J, Shum E, Cummings AL, Kris MG, Sepesi B, Bara I, Kurtsikidze N, Schulze K, Ngiam C, Chaft JE. Lee JM, et al. Among authors: negrao mv. J Thorac Oncol. 2023 Nov;18(11):1458-1477. doi: 10.1016/j.jtho.2023.07.006. Epub 2023 Jul 13. J Thorac Oncol. 2023. PMID: 37451404 Free PMC article. Review.
Immature uterine teratoma associated with uterine inversion.
Souza KT, Negrão MV, da Silva Rocha LS, Di Favero G, da Costa SC, Diz Mdel P. Souza KT, et al. Among authors: negrao mv. Rare Tumors. 2014 Aug 12;6(3):5530. doi: 10.4081/rt.2014.5530. eCollection 2014 Jul 30. Rare Tumors. 2014. PMID: 25276328 Free PMC article.
Exercise training improves muscle vasodilatation in individuals with T786C polymorphism of endothelial nitric oxide synthase gene.
Negrao MV, Alves CR, Alves GB, Pereira AC, Dias RG, Laterza MC, Mota GF, Oliveira EM, Bassaneze V, Krieger JE, Negrao CE, Rondon MU. Negrao MV, et al. Among authors: negrao ce. Physiol Genomics. 2010 Sep;42A(1):71-7. doi: 10.1152/physiolgenomics.00145.2009. Epub 2010 Jul 6. Physiol Genomics. 2010. PMID: 20605946 Clinical Trial.
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.
Robichaux JP, Elamin YY, Vijayan RSK, Nilsson MB, Hu L, He J, Zhang F, Pisegna M, Poteete A, Sun H, Li S, Chen T, Han H, Negrao MV, Ahnert JR, Diao L, Wang J, Le X, Meric-Bernstam F, Routbort M, Roeck B, Yang Z, Raymond VM, Lanman RB, Frampton GM, Miller VA, Schrock AB, Albacker LA, Wong KK, Cross JB, Heymach JV. Robichaux JP, et al. Among authors: negrao mv. Cancer Cell. 2020 Mar 16;37(3):420. doi: 10.1016/j.ccell.2020.03.003. Cancer Cell. 2020. PMID: 32183953 Free PMC article. No abstract available.
63 results